Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory Tecvayli: New Drug for Multiple Myeloma July 25, 2022August 4, 2022 Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.
